Literature DB >> 11572024

Hyperamylasemia and subclinical pancreatitis after cardiac surgery.

A Ihaya1, R Muraoka, Y Chiba, T Kimura, T Uesaka, K Morioka, K Matsuyama, T Tsuda, M Nara, H Niwa.   

Abstract

Hyperamylasemia after cardiac surgery is common but typically causes no clinical concern because it consists mainly of the salivary isoenzyme. In this study we evaluated the incidence, source, and time course of postoperative hyperamylasemia with special attention to the possibility of subclinical pancreatitis. In 88 patients prospectively tested for serum amylase and lipase concentrations, elastase 1 activity, and amylase isoenzyme characteristics, 57 (64%) showed hyperamylasemia during the early postoperative period. In most cases early hyperamylasemia was not of pancreatic origin, but two patients were diagnosed with subclinical pancreatitis. Among the last 23 patients, 5 of 10 patients with early hyperamylasemia exceeding 1000 IU/L showed late hyperamylasemia on the seventh postoperative day, when it represented mainly the pancreatic isoenzyme. Lipase concentrations and elastase 1 activities were elevated in these cases. Late hyperamylasemia following cardiac surgery may be of pancreatic origin and indicative of subclinical pancreatitis, even if early hyperamylasemia was of salivary origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572024     DOI: 10.1007/s00268-001-0041-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

1.  The nature and origin of hyperamylasemia following open-heart surgery with extracorporeal circulation.

Authors:  M Otsuki; M Maeda; H Yuu; T Yamasaki; K Okano
Journal:  Clin Chim Acta       Date:  1977-06-15       Impact factor: 3.786

2.  Hyperamylasemia after cardiac surgery. Incidence, significance, and management.

Authors:  D W Rattner; Z Y Gu; G J Vlahakes; A L Warshaw
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

3.  Postoperative amylase excretion. A study following thoracic surgery with and without extracorporeal circulation.

Authors:  B Hennings; G Jacobson
Journal:  Ann Clin Res       Date:  1974-08

4.  The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass.

Authors:  S K Ohri; S Somasundaram; Y Koak; A Macpherson; B E Keogh; K M Taylor; I S Menzies; I Bjarnason
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

5.  Acute pancreatitis after cardiopulmonary bypass.

Authors:  G S Haas; A L Warshaw; W M Daggett; H T Aretz
Journal:  Am J Surg       Date:  1985-04       Impact factor: 2.565

6.  Risk factors for pancreatic cellular injury after cardiopulmonary bypass.

Authors:  C Fernández-del Castillo; W Harringer; A L Warshaw; G J Vlahakes; G Koski; A M Zaslavsky; D W Rattner
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  Postoperative hyperamylasaemia in cardiac surgery.

Authors:  H Paajanen; A Harmoinen; T Sisto; M Tarkka; I Nordback
Journal:  Scand Cardiovasc J       Date:  1997       Impact factor: 1.589

8.  [Clinical characteristics of pancreatitis after cardiovascular surgery].

Authors:  H Ikegami; T Sumiyoshi; N Ishizuka; M Ueda; T Inaba; S Hosoda; S Aomi; M Endo; A Hashimoto; H Koyanagi
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1995-10

9.  Amylase:creatinine clearance ratios, serum amylase, and lipase after operations with cardiopulmonary bypass.

Authors:  C R Smith; S I Schwartz
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

10.  Incidence and source of hyperamylasemia after cardiac surgery.

Authors:  S C Kazmierczak; F Van Lente
Journal:  Clin Chem       Date:  1988-05       Impact factor: 8.327

View more
  1 in total

1.  A soft pancreatic remnant is associated with increased drain fluid pancreatic amylase and serum CRP levels following pancreatoduodenectomy.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayasidani; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2007-10-23       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.